Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...

Peter Lynch always said that many good stock ideas are right in front of us. Today, when many investors are looking for fast ...